Gold and silver futures prices are modestly up in midday U.S. trading Tuesday. Overnight losses were deemed by the precious metals bulls to be a bargain buying opportunity.
Elemental Advisors Launches PSYK ETF Focused on the Medical Psychedelics Industry
A new U.S.-based psychedelics ETF will begin trading on the NYSE, symbol "PSYK".
Optimi Health Dealer’s License Granted by Health Canada
Optimi Health announces receiving its Dealer's License from Health Canada, allowing the possession, production and sale of psilocybin.
5 Superb Values In Psychedelic Stocks, 5 Different Reasons To Buy
Cheap stocks. Many reasons to invest. We selected five different companies who illustrated these value propositions.
Gold price anchored at $1,800
The gold market remain anchored around $1,800 an ounce following stronger than expected labor market data as fewer American workers applied for initial unemployment benefits last week.
Awakn Life Sciences Receives Bold Price Target From H.C. Wainwright
This morning, Awakn Life Sciences Corp. became the latest psychedelic company to obtain coverage under the H.C. Wainwright umbrella.
Novamind Hosts Clinical Trial to Advance Ketamine Therapy for End-of-Life Patients
Novamind will host a Phase II clinical trial by the Ketamine Research Foundation for ketamine therapy for the terminally ill.
Amendments To Canada's Special Access Program (SAP) Allows Access To Restricted Psychedelic Drugs. How Will This Affect The Industry?
Mental health professionals have been exploring psychedelics as a treatment for substance abuse and mental health disorders for decades, and now its status as a legitimate treatment is being recognized in Canada.
Red Light Holland's Partner CCrest Laboratories Approved By Health Canada to Supply Psilocybin to the Special Access Program
Red Light Holland partner, CCrest Laboratories, has been approved by a Health Canada as a supplier of psilocybin for the SAP.
Price gains for gold, silver on short covering
Gold and silver futures prices higher in early U.S. trading Monday.
Has A Sugar Daddy Emerged In The Psychedelic Drug Industry?
As new deep pockets emerge to finance psychedelic drug development, we also learn that this R&D isn't as expensive as some drug companies claim.
Gold price holds 2-month high ahead of Fed announcement
Gold prices retreated but still held near a two-month high on Wednesday, as investors await the outcome of a US Federal Reserve meeting that may offer more clues on the outlook for monetary policy tightening.
